Phase 2
Completed N=94
Toradol to Reduce Ureteroscopic Symptoms Trial
Urinary Lithiasis · Kidney Diseases · Kidney Stone · Pain, Postoperative
Source: ClinicalTrials.gov NCT03111381 ↗
Enrolled (actual)
94
Serious AEs
0.0%
Results posted
Nov 2021
Primary outcomePrimary: Post-operative Pain — 22; 30 milligram morphine equivalent
Summary
Double blinded randomized controlled clinical trial to assess the impact of intraoperative Toradol on post-operative pain scores for patients undergoing ureteroscopy for urinary stone management.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Post-operative Pain |
22; 30 | — |
| SECONDARY Number of Participants With Complications |
6; 4 | — |
Eligibility Criteria
Inclusion Criteria
- Undergoing Ureteroscopy for kidney stone management between age 18-80.
Exclusion Criteria
- Unable to provide consent
- Contraindications to Toradol
Data sourced from ClinicalTrials.gov (NCT03111381). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.